International registry collaboration is often hampered by regulations preventing transferal of individual patient data between countries. In this issue of Acta, Paxton et al. ([@CIT0005]) report the use of meta-analysis in registry research and compare it with results based on individual-patient level. The meta-analysis approach is well known in medical scientific work, but is not well known among orthopedic surgeons (Arends et al. [@CIT0001]). Using a meta-analysis approach each registry conducts analysis on its own data given a pre-specified protocol and data syntax. The risk estimates are combined in a meta-analysis. The approach was first used in international hip and knee replacement registry research in the United States. The Food and Drug Administration (FDA) funded collaboration between 6 national and regional registries of the International Consortium of Orthopaedic Registries (Sedrakyan et al. [@CIT0007], Cafri et al. [@CIT0002]). Several studies were published from this collaboration reporting results on articulation and fixation of hip prostheses and stabilization of knee replacements (Sedrakyan et al. [@CIT0007]). An important question is whether this approach leads to the same results and estimates as use of individual patient-level data, which have been used in individual registry studies and the Nordic Arthroplasty Register Associations studies (Havelin et al. [@CIT0003], Robertsson et al. [@CIT0006], Johanson et al. [@CIT0004]). In the study by Paxton the meta-analysis approach and individual-level data gave the same results, and adding on one additional registry to the study gave more precise estimates.

The meta-analysis approach demands that a detailed protocol is prepared and a statistical syntax is made by the leading analysis center; this syntax must be used by each individual registry participating in the study. This approach is not flexible and new sub-analysis and small corrections to the protocol demand that the syntax must be redone centrally and new analysis performed. Different statistical approaches can be used such as fixed-effects and random-effects models (Arends et al. [@CIT0001], Cafri et al. [@CIT0002]). Individual-level analysis is more flexible and preferred, but is often impossible since not all registries are allowed to share individual-level data even if they are anonymized. Thus, the US registry was not allowed to contribute to the analysis with individual-level data for privacy and security reasons in the Paxton study. However, the meta-analysis approach as demonstrated by Paxton gave the same results as the individual-level analysis. This is reassuring, as it may convince more registries to contribute data to multinational studies. With the meta-analysis approach each registry has control of its own data and data-ownership issues are of less concern. The known problems of confounding of unknown variables in observational studies such as confounding by indication cannot be accounted for in either individual-level studies or meta-analysis. Both study approaches use time-to-event analysis approaches such as Kaplan--Meier and Cox analysis.
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